ClinicalTrials.gg
CompletedNCT07780864WAYUpdated Aug 25, 2026

Who Are You (WAY) Online Social and Emotional Learning Program for Adolescents

An interventional study of Who Are You (WAY) Social and Emotional Learning Program in Adolescent Development, sponsored by Melih Dikmen. Completed at 1 site in Turkey (Türkiye). Open to participants aged 10 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Melih Dikmen · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Dec 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
All
01

Study summary

This study evaluated the Who Are You (WAY) program, a 10-week online social and emotional learning program designed for adolescents. The program aims to help young people better understand and manage emotions, regulate their behavior, stay motivated in learning, cope with stress, and develop goal-directed skills.

A total of 120 adolescents took part in the study, including 60 middle-school students and 60 high-school students. Within each educational group, participants were randomly assigned either to the WAY program or to a waitlist group that continued with their usual education. The WAY program combined weekly one-to-one online sessions with structured independent learning activities.

Participants completed assessments before and after the 10-week period. The main outcomes were self-regulation, emotional intelligence, academic motivation, and perceived stress. Academic achievement was also assessed as a secondary educational outcome.

The study tested the hypothesis that adolescents assigned to the WAY program would show greater improvement in social-emotional functioning than adolescents assigned to the waitlist condition.

Read the detailed description

This was a two-arm, parallel-group, assessor-blinded, waitlist-controlled randomized trial conducted with two developmentally distinct educational cohorts in Türkiye. Middle-school and high-school participants were randomized separately within cohort in a 1:1 ratio to either the WAY intervention or a waitlist control condition.

WAY was a manualized, digitally supported social and emotional learning intervention delivered over 10 consecutive weeks. Each weekly module included an individual synchronous online session supplemented by structured asynchronous activities. The program addressed self-awareness, emotional understanding and regulation, academic motivation, goal setting, planning, self-monitoring, stress management, adaptive coping, empathy, communication, and maintenance of acquired skills.

Participants in the waitlist condition continued their usual education during the evaluation period and were offered access to the WAY program after completion of post-intervention assessments.

Baseline assessments were completed before randomization, and post-intervention assessments were administered within one week after completion of the intervention period. The four prespecified primary outcome domains were self-regulation, trait emotional intelligence, academic motivation, and perceived stress. Academic achievement was prespecified as a secondary educational outcome. Outcomes were evaluated separately within the middle-school and high-school cohorts.

The trial was completed before registration on ClinicalTrials.gov and is therefore being registered retrospectively.

02

Conditions studied

  • Adolescent Development

Browse trials for

Keywords

  • Social and Emotional Learning
  • Adolescents
  • Self-Regulation
  • Emotional Intelligence
  • Academic Motivation
  • Perceived Stress
  • Academic Achievement
  • Digital Intervention
03

In context

Self-Control

168 studies on the registry are indexed under Self-Control; 22 are open to participants now.

This study's enrollment of 120 is above the median of 88 across 144 interventional studies indexed under Self-Control.

Browse Self-Control studies →

Lead sponsor

This is the only study on the registry with Melih Dikmen as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Enrollment in Grades 5-12.
  • Sufficient proficiency in Turkish to understand the program content and complete the study measures.
  • Reliable internet access and access to an appropriate digital device for participation in the online program.
  • Ability to engage with the program and complete the study measures independently, with reasonable support where required.
  • Written from a parent or legal guardian and written assent from the adolescent.

Exclusion criteria

Exclusion Criteria:

  • Concurrent participation in another structured social and emotional learning program.
  • A cognitive, sensory, linguistic, or functional difficulty that prevented meaningful participation or independent completion of the study measures despite reasonable accommodations.
  • An acute psychological crisis or serious risk requiring immediate professional assessment or clinical support.
  • Failure to complete the baseline assessment or withdrawal before randomization.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    WAY Intervention

    Participants assigned to this arm received the 10-week Who Are You (WAY) social and emotional learning program in addition to their usual education. The program included one individual synchronous online session per week, followed by structured asynchronous learning activities. Each weekly module comprised approximately 30 minutes of synchronous instruction and 15-20 minutes of asynchronous activities.

    Behavioral: Who Are You (WAY) Social and Emotional Learning Program

  • No intervention
    Waitlist Control

    Participants assigned to this arm continued their usual school education and did not receive WAY sessions, facilitator contact, or intervention materials during the 10-week evaluation period. They were offered access to the WAY program after completion of the post-intervention assessment.

Interventions

  • BehavioralWho Are You (WAY) Social and Emotional Learning Program

    WAY is a manualized, digitally supported social and emotional learning program designed for adolescents. It was delivered individually over 10 consecutive weeks. Each weekly module combined a synchronous online session with structured asynchronous activities. The program addressed self-awareness, emotional understanding and regulation, academic motivation, goal setting, planning, self-monitoring, stress management, adaptive coping, empathy, communication, collaborative problem solving, and maintenance of acquired skills. Sessions used guided discussion, reflective questioning, experiential activities, structured exercises, individualized reflection, and goal setting.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Perceived Self-Regulation Scale Score

    Self-regulation in the middle-school cohort was assessed using the 16-item Perceived Self-Regulation Scale. Items are rated on a 5-point Likert-type scale. Total scores are calculated by summing item responses, with higher scores indicating greater perceived self-regulatory capacity.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

  2. Change From Baseline in Self-Regulation Scale for Adolescents Score

    Self-regulation in the high-school cohort was assessed using the 11-item Self-Regulation Scale for Adolescents. The scale assesses goal setting, planning, monitoring, emotional awareness, and behavioral control using a 5-point response format. Higher total scores indicate greater self-regulatory competence.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

  3. Change From Baseline in Trait Emotional Intelligence Questionnaire-Adolescent Short Form Score

    Trait emotional intelligence was assessed in both cohorts using the 15-item Trait Emotional Intelligence Questionnaire-Adolescent Short Form (TEIQue-ASF). Items are rated on a 7-point scale. Negatively worded items are reverse scored, and higher total scores indicate greater perceived emotional competence.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

  4. Change From Baseline in Academic Motivation Scale Score in Middle-School Studen

    Academic motivation in the middle-school cohort was assessed using the 28-item Turkish adaptation of the Academic Motivation Scale. Items are rated on a 7-point scale. Total scores are calculated after appropriate reverse scoring, with higher scores indicating stronger academic motivation.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

  5. Change From Baseline in Academic Motivation Scale Score in High-School Students

    Academic motivation in the high-school cohort was assessed using the 22-item Turkish Academic Motivation Scale. Items assess intrinsic motivation, extrinsic motivation, and amotivation and are rated on a 7-point scale. Higher total scores indicate stronger academic motivation after appropriate reverse scoring.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

  6. Change From Baseline in Perceived Stress Scale for Children Score

    Perceived stress in the middle-school cohort was assessed using the 9-item Perceived Stress Scale for Children. Items are rated on a 4-point frequency scale. Total scores are calculated by summing item responses, with higher scores indicating greater perceived stress.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

  7. Change From Baseline in Perceived Stress Scale

    Perceived stress in the high-school cohort was assessed using the 10-item Perceived Stress Scale (PSS-10). Items are rated from 0 (Never) to 4 (Very often). Positively worded items are reverse scored before calculating the total score, with higher scores indicating greater perceived stress.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

Secondary outcomes

  1. Change From Baseline in Middle School Academic Achievement Test Score

    Academic achievement in the middle-school cohort was assessed using the 75-item Middle School Academic Achievement Test (MS-AAT), covering Turkish language, social studies, mathematics, and science. Items are scored 1 for a correct response and 0 for an incorrect or omitted response, with higher total scores indicating greater academic achievement.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

  2. Change From Baseline in High School Academic Achievement Test Score

    Academic achievement in the high-school cohort was assessed using the 80-item High School Academic Achievement Test (HS-AAT), covering curriculum-based academic domains. Items are scored 1 for a correct response and 0 for an incorrect or omitted response, with higher total scores indicating greater academic achievement.

    Time frame: Baseline and post-intervention, within 1 week after completion of the 10-week program

07

Study locations

1 site
  • Fırat University
    Elâzığ, 23119, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in the publication will be shared together with the corresponding data dictionary and analytic code.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: Data will be available following publication of the primary study report and will remain available without a predefined end date.

Access criteria: Data will be publicly available without individual application or approval requirements through an open research repository for research and verification purposes.

Data sharing details ↗ · doi.org

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Mar 2026, 3 months.

Of 104 non-industry interventional studies with no phase under Self-Control, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 34. This study's 3 months is below that.

Counting every sponsor, half of 105 studies reached it within 16 months; a quarter within 5 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2026
First posted
Aug 24, 2026
StartActual
Dec 15, 2025
Primary completionActual
Mar 27, 2026
CompletionActual
Mar 27, 2026
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07780864
Lead sponsor
Melih Dikmen
Responsible party
Melih Dikmen (Associate Professor, Firat University) — Sponsor-investigator
First posted
Aug 24, 2026
Start date
Dec 15, 2025
Primary completion
Mar 27, 2026
Completion
Mar 27, 2026
Last update
Aug 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion